Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

NCT04160897 · clinicaltrials.gov ↗

UNKNOWN

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic
Hepatocellular Carcinoma
Compensated Cirrhosis

Interventions

DRUG: Entecavir
DRUG: Tenofovir Disoproxil

Sponsor

Qing XIe

Collaborators

[object Object]